Hoppa till huvudinnehållet
Till KTH:s startsida

CB2020 Clinical applications of biotechnology 7.5 credits

Course memo Autumn 2026-10056

Version 2 – 07/23/2026, 10:10:07 AM

Course offering

Autumn 2026-10056 (Start date 24 Aug 2026, English)

Language Of Instruction

English

Offered By

CBH/Protein Science

Course memo Autumn 2026

Headings denoted with an asterisk ( * ) is retrieved from the course syllabus version Autumn 2026

Content and learning outcomes

Course contents

The course in Clinical Applications of Biotechnology provides an orientation on biotechnological methods and measurements used in healthcare. The course provides both theoretical background and practical application of analytical methods. The course includes basic knowledge of molecular disease mechanisms, biomarkers, molecular biology tools and methods. New developments with the potential to be integrated in a clinical context are highlighted. The course includes elements that focus on ethics and sustainability.

Intended learning outcomes

Knowledge and understanding

After passing the course the student must be able to:

  • Describe concepts relating to biotechnology that are applied in the clinic
  • Explain in detail the principles for methods and measurements of biological samples and relate them to clinical diagnosis and treatment.
  • Elaborate on how clinical applications of biotechnology are applied in the clinic, including from a development perspective.

Skills and abilities

After passing the course the student must be able to:

  • Relate biotechnological applications to underlying molecular disease mechanisms.
  • Be able to apply measurements of diagnostic markers and report results in writing and orally.

Values and approaches

After passing the course the student must be able to:

  • Suggest biotechnological applications for clinical use and explain their benefits and disadvantages.
  • Reflect on the clinical use of biotechnology from an ethical, economic, ecological, and social perspective.

Learning activities

Lectures: 14, along with a 1-hour lab introduction, on-site

Reading assignments: Scientific articles, textbook, and lab protocols.

Scientific quizzes: Relating to the scientific articles.

Laboratory work microfluidics: One-day lab/demonstration (LAB3, approx. 6 hours)

Laboratory work treatment-predictive marker assessment: Two-day wet lab (LAB4, approx. 6 hours per day). The lab covers immunohistochemistry and qPCR (incl. primer design), an individual lab report, and peer review.

Writing assignment and presentation: Societal impact module focusing on ethics and sustainability in biotechnology in health care, includes group work (SEM1).

Detailed plan

SCHEDULED ACTIVITIES (May be changed, check up-to-date schedule and classrooms at KTH.se)

Compulsory attendance: LAB3 (one occasion), LAB4 (1 h lecture and 2-day lab), and SEM (presentation, one occasion). See Canvas for groups and the schedule for times and locations.

LECTURES:

Date Lecture  Topic  Module  Teacher
25/8 1 Introduction, Basic Concepts, Perspectives 1 Cecilia Williams
26/8 2 Breast Cancer Biomarkers and Treatment I  3 Cecilia Williams
27/8 3 Breast Cancer Biomarkers and Treatment II  3 Cecilia Williams
28/8 LAB Theory and Preparation for Lab  LAB4  Amena Archer
28/8 4 Breast Cancer Imaging and AI Applications  2

Fredrik Strand (guest lecturer) 

31/8 5 Ethical, Societal, and Economic Impacts 7 Cristina Al-Khalili Szigyarto
1/9 6

Microfluidics, Point-of-Care Devices I 

5 Aman Russom
3/9 7  Pathology, Cancer Imaging, AI Applications  2 Stephanie Robertsson (guest lecturer) 
8/9 8 Breast Cancer Biomarkers and Treatment III 3 Cecilia Williams
11/9 9

Cancer Detection & Treatment, Future

4 Cecilia Williams
15/9 10

Microfluidics, Point-of-Care Devices II 

5

Aman Russom

18/9 11

Microfluidics, Point-of-care devices III

5 Aman Russom
28/9 12 Microfluidics, Point-of-Care Devices IV 5 Aman Russom
29/9   Midterm Results, Q&A, Course Evaluation   Cecilia Williams 
7/10 13  Cardiovascular and Homeostatic Diseases I  6 Jacob Odeberg
9/10 14 Cardiovascular and Homeostatic Diseases II 6 Jacob Odeberg

 

LAB and DEBATE SCHEDULE:

GROUP

LAB3 

LAB4 

LAB4 First draft submission

LAB4 Peer review

LAB4 Final submission

SEM1 presentation

1A

17/9

1/9 + 2/9

9/9

14/9

17/9

one occasion

1B

23/9

1/9 + 2/9

9/9

14/9

17/9

one occasion

2A

24/9

3/9 + 4/9

11/9

16/9

21/9

one occasion

2B

25/9

3/9 + 4/9

11/9

16/9

21/9

one occasion

3A

28/9

7/9 + 8/9

15/9

18/9

23/9

one occasion

3B

1/10

7/9 + 8/9

15/9

18/9

23/9

one occasion

4A

6/10

9/9 + 10/9

17/9

22/9

25/9

one occasion

4B

7/10

9/9 + 10/9

17/9

22/9

25/9

one occasion

5A

11/9

15/9 + 16/9

23/9

28/9

1/10

one occasion

5B

8/10

15/9 + 16/9

23/9

28/9

1/10

one occasion

6A

15/9

22/9 + 23/9

30/9

5/10

8/10

one occasion

6B

16/9

22/9 + 23/9

30/9

5/10

8/10

one occasion

 

Course Objectives

To pass the course, you must be able to [examinated by]:

1. Describe the use of biological samples for the purpose of diagnosing health conditions and explaining their advantages and disadvantages [TEN2/LAB3/LAB4]
 
2. Describe different types of biomarkers and their occurrence and relation to diseases and treatments. [TEN2/LAB3/LAB4]
 
3. Explain biotechnological methods, technologies, and measurements used clinically to identify and quantify different types of biomarkers [TEN2/LAB3/ LAB4]
 
4. Explain and evaluate the biotechnological applications used for screening, diagnosis, and treatment of breast cancer and cardiovascular and hemostatic diseases [TEN2/LAB4]
 
5. Independently carry out and interpret measurements of various biomarkers for diagnostic purposes and report results in writing and/or orally [LAB3/LAB4/TEN2]
 
6. Explain the underlying molecular mechanisms that make different types of drug treatment effective [TEN2/LAB4]
 
7. Explain medical image analysis for screening and diagnostic purposes [TEN2/LAB4]
 
8. Describe the development and use of 'Point-of-care' diagnostics [TEN2/LAB3]
 
9. Understand, and reflect on, the clinical use of biotechnology from an ethical, economic, ecological, and social perspective [TEN2/LAB3/LAB4/SEM1]
 
10. Reflect on and discuss ethical issues in the field. [SEM1/TEN2]

Preparations before course start

Specific preparations

Kahoot may be used in some classes. When prompted, go to www.kahoot.it or download app in advance.

Lab preparations: Before the lab, read through the important safety information provided in Canvas and attend the compulsory preparatory LAB lecture.

Literature

Medical Biotechnology, by Glick, Delowitch, and Patten, ASM Press, 2014 (e-book available freely through KTHB: via link)

Scientific articles (provided in Canvas)

Please inform the course coordinator if you have special needs not related to the written exam, and show your certificate from Funka.

  • Support measures under code R (i.e., adjustments related to space, time, and physical circumstances, e.g., longer writing time) are always granted.
  • Support measures under code P (pedagogical measures) may be granted or rejected by the examiner after you have applied for this in accordance with KTH rules.

Examination and completion

Grading scale

A, B, C, D, E, FX, F

Examination

  • TEN2 - Written exam, 4.0 credits, grading scale: A, B, C, D, E, FX, F
  • LAB3 - Laboratory work, 0.5 credits, grading scale: P, F
  • LAB4 - Laboratory work, 2.0 credits, grading scale: P, F
  • SEM1 - Seminar, 1.0 credits, grading scale: P, F

Based on recommendation from KTH’s coordinator for disabilities, the examiner will decide how to adapt an examination for students with documented disability.

The examiner may apply another examination format when re-examining individual students.

If the course is discontinued, students may request to be examined during the following two academic years.

The section below is not retrieved from the course syllabus:

Other requirements for examination:
 
Bonus points are given that are added to the exam points (Part A or B) according to the following:
Societal impact module (SEM1): Well-performed within deadlines can generate up to 2 bonus points [to Part A]
Lab Report (LAB4): Well-performed within deadlines can generate up to 2 bonus points [to Part A]
Completion of 4 scientific quizzes (>75% correct answers) within deadlines can generate up to 2 bonus points [to Part B]

Other requirements for final grade

There are elements with compulsory attendance.

Grading criteria/assessment criteria

For higher grades (A-D), more profound knowledge is required within the essential parts of the course, and the student can, to varying degrees, interconnect, reason, and apply their knowledge to tackle increasingly complex biotechnological problems [TEN2]. 

The exam is in two parts:

Part A comprises 7 modules, and each needs to be passed (>75% ) for grade E. A Midterm Exam offers the possibility to examine modules 1-3 ahead of the Final Exam.

Part B comprises 5 essay questions for higher grades (max points: 30 points + up to 2 bonus points)

Grading scheme (tentative, may be adjusted):

E  Completed compulsory quizzes, laboratory work [LAB3 and LAB4], approved societal impact debate, and approved PART A (at least 75% on each of the 7 modules) [TEN2]

D also, explain in greater detail different clinical applications of biotechnology, with examples, examined in PART B (at least 16 points)[TEN2]

C also, explain in greater detail in several parts of the course, with examples and analysis of the benefits and disadvantages examined in PART B (at least 19 points) [TEN2]

B in addition, theoretically apply advanced knowledge in all parts of the course to address biotechnological issues within the clinic, examined in PART B (at least 22 points) [TEN2]

A in addition, theoretically apply very advanced knowledge, in all parts of the course, to tackle particularly complicated biotechnological issues within the clinic, examined in PART B (at least 25 points) [TEN2]

 

 

Opportunity to complete the requirements via supplementary examination

If one topic is failed on Part A [TEN2], this generates the grade Fx. Fx can be supplementary examined through oral examination within 14 working days following the grading (if requested).

Opportunity to raise an approved grade via renewed examination

Contact examiner.

Alternatives to missed activities or tasks

As far as possible, students can change lab groups or debate sessions with each other (note, some activities are overlapping between groups). If so, the students should inform the course responsible. 

For further questions, contact the course coordinator.

Reporting of exam results

The exam result will be shown in Canvas.

The final grade on the course will be reported through LADOK.

Ethical approach

  • All members of a group are responsible for the group's work.
  • In any assessment, every student shall honestly disclose any help received and sources used.
  • In an oral assessment, every student shall be able to present and answer questions about the entire assignment and solution.

The section below is not retrieved from the course syllabus:

 

Plagiarism: The LAB report is written by the student individually, and a white paper is written as a group assignment. Plagiarism is not allowed. Plagiarism is copying the work of others, which could be online or print sources, your peers, or others. If the source can be identified with high statistical significance and is not attributed directly and explicitly, it is plagiarism. This is considered cheating and will be reported.

Use of artificial intelligence (AI): In the same way that plagiarism is not allowed, it is also not allowed to let an AI tool write the text. AI tools, however, may be used as a help to find information or to improve the language and flow of the text. If AI has been used for any such purposes, this should be transparent and must be stated in the report. Tools used for simple reference formatting or grammar do not need to be stated. 

 

Further information

Additional regulations

Course syllabus for CB2020 valid from Autumn 2024

Changes of the course before this course offering

The course syllabus has been slightly altered, and credits for laboratory work, seminar (writing assignment, presentation), and exam adjusted. The content of the course has been updated. Canvas modules have been slightly changed for clarity, and lectures have been updated.

Round Facts

Start date

24 Aug 2026

Course offering

  • Autumn 2026-10056

Language Of Instruction

English

Offered By

CBH/Protein Science

Contacts

Communication during course

Use email to communicate with examinator, course responsible, lab responsible, or teachers.

Course Coordinator

Teachers

Examiner